Mbaki Y, Ramage A G
Department of Pharmacology, University College London, Hampstead Campus, Rowland Hill Street, London NW3 2PF, UK.
Br J Pharmacol. 2008 Oct;155(3):343-56. doi: 10.1038/bjp.2008.273. Epub 2008 Jul 7.
Micturition is controlled by central 5-HT-containing pathways. 5-HT2 receptors have been implicated in this system especially in control of the urethra, which is a drug target for treating urinary incontinence. This study investigates the role of each of the three subtypes of this receptor with emphasis on sphincter regulation.
Recordings of urethral and bladder pressure, external urethral sphincter (EUS) EMG, as well as the micturition reflex induced by bladder distension along with blood pressure and heart rate were made in anaesthetized rats. The effects of agonists and antagonists for 5-HT2 receptor subtypes were studied on these variables.
The 5-HT2C agonists Ro 60-0175, WAY 161503 and mCPP, i.v., activated the EUS, increased urethral pressure and inhibited the micturition reflex. The effects of Ro 60-0175 on the EUS were blocked by the 5-HT2C antagonist SB 242084 and the 5-HT2A antagonists, ketanserin and MDL 100907. SB 242084 also blocked the inhibitory action on the reflex, while the 5-HT2B antagonist RS 127445 only blocked the increase in urethral pressure. The 5-HT2A receptor agonist DOI given i.v. or i.t. but not i.c.v. activated the EUS.
5-HT2A/2C receptors located in the sacral spinal cord activate the EUS, while central 5-HT2C receptors inhibit the micturition reflex and 5-HT2B receptors, probably at the level of the urethra, increase urethral smooth muscle tone. Furthermore, 5-HT2B and 5-HT2C receptors do not seem to play an important role in the physiological regulation of micturition.
排尿受中枢含5-羟色胺(5-HT)通路的控制。5-HT2受体参与了该系统,特别是在尿道控制方面,而尿道是治疗尿失禁的药物靶点。本研究着重于括约肌调节,探究该受体三种亚型各自的作用。
在麻醉大鼠身上记录尿道和膀胱压力、尿道外括约肌(EUS)肌电图,以及膀胱扩张诱发的排尿反射,同时记录血压和心率。研究了5-HT2受体亚型激动剂和拮抗剂对这些变量的影响。
5-HT2C激动剂Ro 60-0175、WAY 161503和间氯苯哌嗪静脉注射可激活EUS,增加尿道压力并抑制排尿反射。Ro 60-0175对EUS的作用被5-HT2C拮抗剂SB 242084以及5-HT2A拮抗剂酮色林和MDL 100907阻断。SB 242084也阻断了对反射的抑制作用,而5-HT2B拮抗剂RS 127445仅阻断尿道压力的升高。5-HT2A受体激动剂DOI静脉注射或经皮内注射(而非脑室内注射)可激活EUS。
位于骶髓的5-HT2A/2C受体激活EUS,而中枢5-HT2C受体抑制排尿反射,5-HT2B受体可能在尿道水平增加尿道平滑肌张力。此外,5-HT2B和5-HT2C受体在排尿的生理调节中似乎不起重要作用。